Author profile
Department of Radiation Oncology, UT Southwestern Medical Center
Simulation-omitted prostate SBRT (SO-PRO) has potential to reduce treatment delays and expand access to care but presents unique challenges for SBRT workflows that require careful management of target and organ-at-risk (OAR) dose. A major barrier is diagnosti...
Stereotactic ablative radiotherapy (SAbR) achieves high local control in patients with oligometastatic renal cell carcinoma (omRCC), but a subset of patients experience early progression due to occult micrometastatic disease and may not benefit from an oligom...
Stereotactic ablative radiotherapy (SAbR) has demonstrated efficacy in controlling oligometastatic renal cell carcinoma (omRCC) with safely delayed systemic therapy. However, a subset of patients has limited benefit from SAbR, which may require upfront system...
To quantify renal parenchyma functional changes in response to radiation dose for patients treated with kidney stereotactic body radiotherapy (SBRT) by analyzing the paired pre- and post-treatment contrast-enhanced CT scans. We hypothesize that radiation indu...